Arcara Jeffrey
Reporting owner on Forms 3, 4 and 5, CIK 2010430.
Arcara Jeffrey reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-13.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CRVS · Corvus Pharmaceuticals, Inc.CIK 1626971 | officer (Chief Business Officer) | 1 | 2026-11-13 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CRVS · Corvus Pharmaceuticals, Inc.Common Stock | 2026-11-13 | P bought | +503 | $10.37 | 4,000 | Form 4 |
| CRVS · Corvus Pharmaceuticals, Inc.Common Stock | 2026-11-13 | P bought | +500 | $10.7087 | 4,500 | Form 4 |
| CRVS · Corvus Pharmaceuticals, Inc.Common Stock | 2026-11-12 | P bought | +497 | $11.115 | 3,497 | Form 4 |
| CRVS · Corvus Pharmaceuticals, Inc.Common Stock | 2026-11-11 | P bought | +3,000 | $11.4602 | 3,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001610717-26-000454 | Corvus Pharmaceuticals, Inc. | 2026-11-13 |